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Evaluating the outcomes of tuberculosis treatment and understanding the speciﬁc reasons
for  unfavorable treatment outcome are important in evaluating the effectiveness of tubercu-
losis control program. A retrospective study was conducted to assess tuberculosis treatment
outcomes and associated factors among smear positive pulmonary tuberculosis patients in
zone-one health facilities of Afar regional state, Ethiopia. A total of 380 smear positive pul-
monary tuberculosis patients’ registration book recorded with complete information from
Jan  2011 to Dec 2013 were analyzed. Of 380 patients included in the analysis, 238 were male
and  142 female with mean age of 30.7. Overall treatment outcome were 128 (33.7%) cured,
192  (50.2%) completed, 17 (4.5%) died, 1 (0.3%) treatment failure, 34 (8.9%) default and 8 (2.1%)
transfer out. Treatment success rate was 81.8%. There was statistically signiﬁcance associ-
ation between age (p-value = 0.000), sex (p-value = 0.018), HIV status (p-value = 0.000), four
week attendance (p-value = 0.000), sputum follow up test (p-value = 0.000), and treatment
outcome year (p-value = 0.000), and treatment success (p-value = 0.000). Treatment success
rate almost reached to the WHO  targets although yet need to work a lot for fulﬁllment of
global targets. Regular four week attendance in continuation phase and doing follow upsputum test with unsuccessful outcome for smear positive tuberculosis patient were vital.
©  2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an
open  access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
situation might affect treatment outcomes. A retrospective
uberculosis (TB) is the leading cause of morbidity and mor-
ality in the world; it remains a major global health problem.1he number of TB deaths is unacceptably high given that most
re preventable if people can access health care for a diag-
osis and the right treatment is provided.2 However, factors
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such as access to care and a person’s social and ﬁnancialcross-sectional study was carried out to assess treatment out-
come of TB patients registered from Jan 2011 to Dec 2013
in zone one of Afar region, Ethiopia. Univariate and binary
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Table 1 – Logistic regression analysis of different factors associated with sputum smear-positive pulmonary tuberculosis
patients in Afar region, Ethiopia.
Variables Unsuccessful Successful COR (95% CI) AOR (95% CI) p-Value
Age
0–14 18 (56.2%) 14 (43.8%) 0.919 (0.398–2.126) 1.086 (0.353–3.338) 0.886
15–40 12 (4.3%) 264 (95.7%) 6.000 (12.388–54.567) 0.029 (0.011–0.080) 0.000
40+ 39 (54.2%) 33 (45.8%) 1.00 1.00
Sex
Male 54 (22.7%) 184 (77.3%) 0.402 (0.218–0.744) 2.526 (1.023–6.233) 0.044
Female 15 (10.6%) 127 (789.4%) 1.00 1.00
HIV status
Non-reactive 47 (14.7%) 272 (85.3%) 3.265 (1.778–5.993) 0.131 (0.046–0.373) 0.000
Reactive 22 (36.1%) 39 (63.95) 1.00 1.00
FWA
No 49 (39.5%) 75 (60.5%) 0.130 (0.073–0.232) 5.585 (2.438–12.793) 0.000
Yes 20 (7.8%) 236 (92.2%) 1.00 1.00
SFUT
No 48 (29.8%) 113 (70.2%) 0.250 (0.142–0.438) 7.541 (3.022–18.818) 0.000
Yes 21 (9.6%) 198 (90.4%) 1.00 1.00
r
1
2
3
4FWA, four-week attendance in CP; SFUT, sputum follow up test.
logistic regression analysis was done to identify factors that
were associated with treatment outcomes (favorable or unfa-
vorable). Ethical approval was obtained from the Health
Science Research Ethical Committee of Samara University in
Afar region, Ethiopia.
A total of 380 patients’ records with complete information
were analyzed. A total of 238 were male and 142 female with an
overall mean age of 30.7 years. The global treatment outcomes
were 128 (33.7%) cured, 192 (50.2%) completed, 17 (4.5%) died,
1 (0.3%) treatment failure, 34 (8.9%) defaulted, and 8 (2.1%)
transferred out. The overall treatment success rate was 81.8%
(311). Among different health facilities treatment success rate
ranged from 70.9% to 89.3%. This rate has improved with time.
The variables age, sex, HIV status, four-week attendance, spu-
tum follow up test, and year of treatment were signiﬁcantly
associated with treatment success (Table 1).
In the present study female patients were more  likely
to have successful treatment outcome compared to male
patients (89.4% versus 77.3%; p-value = 0.004). This ﬁnding is
in line with that reported by Tessema et al.3 Patients aged
more than 40 years old were more  likely to have unsuccess-
ful treatment outcome (p-value = 0.000). Treatment outcomes
in the present study were consistent with those reported by
Tweya et al., which showed 86% of treatment success (com-
pleted plus cured), 5% died, 1% had treatment failure, 2% were
transferred out, 6% defaulted.4 In contrast, treatment out-
comes were rather distinct from those reported in a study by
Tessema et al., in which 29.5% were cure + completed, 18.3%
5defaulted, 10.1% died, 0.2% had treatment failure, and 42.0%
were transferred out.3
The overall treatment success rate of the present study
(81.8%) is similar to that found by Hamusse et al. (83.6%).5
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